MedTrace Logo

The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation

NCT06080035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-08-28

No results posted yet for this study

Summary

The purpose of this study is to assess the effects of Cetyl Tranexamate Mesylate on acne-related hyperpigmentation through a specific delivery form known as TeraCeutic TXVector.

Conditions

  • Hyperpigmentation
  • Post-inflammatory Hyperpigmentation
  • Acne

Interventions

OTHER

Topical Cetyl Tranexamate Mesylate

Topical product will be applied onto clean skin morning and night.

Sponsors & Collaborators

  • Actera

    collaborator UNKNOWN

  • Integrative Skin Science and Research

    lead INDUSTRY

Principal Investigators

  • Raja Sivamani, MD MS AP · Integrative Skin Science and Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-06
Primary Completion
2024-01-11
Completion
2024-01-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06080035 on ClinicalTrials.gov